Health Invest Partners Ab has filed its 13F form on November 04, 2025 for Q3 2025 where it was disclosed a total value porftolio of $231 Million distributed in 38 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $28.4M, Abb Vie Inc. with a value of $21.3M, Neurocrine Biosciences Inc with a value of $14.4M, Merck & Co., Inc. with a value of $13.5M, and Thermo Fisher Scientific Inc. with a value of $13.2M.

Examining the 13F form we can see an increase of $9.46M in the current position value, from $221M to 231M.

Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.

Portfolio value $231 Million
Healthcare: $231 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 38
  • Current Value $231 Million
  • Prior Value $221 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 04, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 2 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.